This inventor holds 2 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 2 EPO patents. Top assignees: Actelion Pharmaceuticals Ltd, Idorsia Pharmaceuticals Ltd. Active years: 2016-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2018
Title: Anja Valdenaire: Innovator in Pharmaceutical Modulation
Introduction
Anja Valdenaire is a prominent inventor based in Basel, Switzerland. She has made significant contributions to the field of pharmaceuticals, particularly in the development of receptor modulators. With a total of 2 patents to her name, Valdenaire's work is recognized for its innovative approach to drug formulation and therapeutic applications.
Latest Patents
Valdenaire's latest patents include groundbreaking inventions such as CXCR7 receptor modulators. This invention relates to derivatives of a specific formula, which are designed for use as pharmaceuticals and in pharmaceutical compositions. Another notable patent is for 1-[m-carboxamido(hetero)aryl-methyl]-heterocyclyl-carboxamide derivatives, which focuses on compounds that hold promise for various therapeutic applications.
Career Highlights
Throughout her career, Anja Valdenaire has worked with leading companies in the pharmaceutical industry, including Actelion Pharmaceuticals Ltd and Idorsia Pharmaceuticals Ltd. Her experience in these organizations has allowed her to refine her expertise and contribute to significant advancements in drug development.
Collaborations
Valdenaire has collaborated with esteemed colleagues such as Heinz Fretz and Philippe Guerry. These partnerships have fostered a collaborative environment that enhances innovation and drives research forward.
Conclusion
Anja Valdenaire's contributions to pharmaceutical innovation exemplify her dedication to advancing medical science. Her patents and collaborations reflect her commitment to improving therapeutic options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

